CBC on Virtual Tour: Precision breast cancer medicine – how is research helping us to treat breast cancer more precisely?

November 1, 2021

Join Professor Jean Abraham to hear how combining cutting-edge research into different types of breast cancer with clinical trials aims to deliver more precise treatment for individual patients.

Professor Jean Abraham is an Academic Honorary Consultant in Medical Oncology and Professor of Precision Breast Cancer Medicine at the University of Cambridge. As well as treating breast cancer patients in clinic and conducting clinical research, she is Director of the Cambridge Breast Cancer Unit at Addenbrooke’s and co-leads the Integrated Cancer Medicine Programme at the Cancer Research UK Cambridge Centre.

Jean has a particular interest in the management and treatment of high risk and hereditary breast cancers. She is actively involved in the design and development of biomarker directed clinical trials which aim to treat patients in a more targeted fashion with fewer side effects, earlier in their treatment pathway. She also co-leads the pioneering Personalised Breast Cancer Programme which reads tumour DNA and RNA information like a barcode to tailor treatment for breast cancer patients. The Programme has enrolled over 800 breast cancer patients at Addenbrooke’s and has recently opened in Oxford.

This event is part of the ‘CBC on Virtual Tour’ series – the chance to learn more about the Cambridge Biomedical Campus where over 20,000 people at the forefront of the changing face of healthcare are working.

This free event will be recorded and a link will be sent to all participants afterwards. It will also be posted on the CUHP website and the Cambridge Biomedical Campus YouTube channel.

Photo credit: National Human Genome Research Institute

Book your place

 

An article in the Cambridge Independent features Professor Jean Abraham talking about her work in personalised breast cancer medicine ahead of her CBC on Virtual Tour talk.

CBC on Virtual Tour: Precision breast cancer medicine – how is research helping us to treat breast cancer more precisely?
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect